Danielle Gerhard, PhD | Mar 22, 2024 | 10+ min read
With the help of directed evolution, scientists inch closer to developing viral vectors that can cross the human blood-brain barrier to deliver gene therapy.
Scientists discuss their latest findings on immune cell dynamics, neurodegenerative disease risk factors, and rare cell types obtained from bulk and single cell RNA sequencing experiments.
Ian Wilmut(ian.wilmut@bbsrc.ac.uk) | Apr 24, 2005 | 6 min read
The ability to derive embryonic stem cells from cloned human embryos and to control their differentiation into different cell types provides revolutionary new opportunities in biology and medicine.